Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith S Kaye

Showing results (141-150 of 421) with videos related to

Pageof 43
Sort By:
Plos One|November 25, 2015
Rising United States Hospital Admissions for Acute Bacterial Skin and Skin Structure Infections: Recent Trends and Economic ImpactKeith S Kaye, Dipen A Patel, Jennifer M Stephens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Acceptable rates of treatment failure in osteomyelitis involving the diabetic foot: a survey of infectious diseases consultantsEli N Perencevich, Keith S Kaye, Larry J Strausbaugh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2002
Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coliAnthony D Harris, Matthew H Samore, Marc Lipsitch, et al.
Infection Control and Hospital Epidemiology|January 4, 2008
Surgical site infections after laparoscopic and open cholecystectomies in community hospitals Luke F Chen, Deverick J Anderson, Matthew G Hartwig, et al.
Open Forum Infectious Diseases|May 1, 2023
Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative BacteremiaNikki N Tran, Ryan P Mynatt, Keith S Kaye, et al.
American Journal of Infection Control|March 4, 2014
Effectiveness and cost of implementing an active surveillance screening policy for Acinetobacter baumannii: a Monte Carlo simulation modelJoseph R Coyle, Keith S Kaye, Thomas Taylor, et al.
American Journal of Infection Control|April 4, 2015
Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction ProgramTeena Chopra, Anupama Neelakanta, Carolyn Dombecki, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing EnterobacteriaceaeMitchell J Schwaber, Shiri Navon-Venezia, Keith S Kaye, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Challenges and Opportunities in Antimicrobial Stewardship among Hematopoietic Stem Cell Transplant and Oncology PatientsAnjali Majumdar, Mansi R Shah, Jiyeon J Park, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patientsAnthony D Harris, Eli Perencevich, Mary-Claire Roghmann, et al.
Pageof 43

Showing results (141-150 of 421) with videos related to

Sort By:
Pageof 43
Plos One|November 25, 2015
Rising United States Hospital Admissions for Acute Bacterial Skin and Skin Structure Infections: Recent Trends and Economic ImpactKeith S Kaye, Dipen A Patel, Jennifer M Stephens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Acceptable rates of treatment failure in osteomyelitis involving the diabetic foot: a survey of infectious diseases consultantsEli N Perencevich, Keith S Kaye, Larry J Strausbaugh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2002
Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coliAnthony D Harris, Matthew H Samore, Marc Lipsitch, et al.
Infection Control and Hospital Epidemiology|January 4, 2008
Surgical site infections after laparoscopic and open cholecystectomies in community hospitals Luke F Chen, Deverick J Anderson, Matthew G Hartwig, et al.
Open Forum Infectious Diseases|May 1, 2023
Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative BacteremiaNikki N Tran, Ryan P Mynatt, Keith S Kaye, et al.
American Journal of Infection Control|March 4, 2014
Effectiveness and cost of implementing an active surveillance screening policy for Acinetobacter baumannii: a Monte Carlo simulation modelJoseph R Coyle, Keith S Kaye, Thomas Taylor, et al.
American Journal of Infection Control|April 4, 2015
Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction ProgramTeena Chopra, Anupama Neelakanta, Carolyn Dombecki, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing EnterobacteriaceaeMitchell J Schwaber, Shiri Navon-Venezia, Keith S Kaye, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Challenges and Opportunities in Antimicrobial Stewardship among Hematopoietic Stem Cell Transplant and Oncology PatientsAnjali Majumdar, Mansi R Shah, Jiyeon J Park, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patientsAnthony D Harris, Eli Perencevich, Mary-Claire Roghmann, et al.
Pageof 43